An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for Helminths
NCT01271049 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2012-12-12
Summary
The prevalence of intestinal helminths is worldwide. This study will evaluate the tolerability of a novel food product consumed by adults residing in an area endemic for helminths.
Conditions
- Helminthiasis
Interventions
- OTHER
-
Novel Food Product
Novel food product containing essential oil blend
- OTHER
-
Control Food Product
Control food product
Sponsors & Collaborators
-
TyraTech Technology
collaborator UNKNOWN -
Mondelēz International, Inc.
lead INDUSTRY
Principal Investigators
-
David Diemert, MD, FRCP(C) · Rene Rachou Research Center, Brazil
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- Brazil
Study Locations
More Related Trials
-
Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome
NCT02057692 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
NCT01471652 ·Status: WITHDRAWN ·Phase: PHASE2
-
Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
NCT01872351 ·Status: WITHDRAWN
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
A Multi-center Evaluation of Aldafermin in a Randomized, Double-blind, Placebo-controlled Study in Subjects With Primary Sclerosing Cholangitis.
NCT06654726 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Effect of Polyphenol Supplementation on Hepatic Steatosis and Vascular Compliance
NCT03994029 ·Status: RECRUITING ·Phase: NA
-
The Role of Microbiome Reprogramming on Liver Fat Accumulation
NCT03914495 ·Status: TERMINATED ·Phase: NA
-
Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
NCT00004697 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study
NCT02255617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)
NCT01793415 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
NCT00004368 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia
NCT00004809 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
NCT06910943 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
NCT00281502 ·Status: UNKNOWN ·Phase: PHASE2
-
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals
NCT06610695 ·Status: ENROLLING_BY_INVITATION
-
Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis
NCT02024295 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
NCT05314374 ·Status: COMPLETED ·Phase: PHASE1
-
The 8x5 Diet for Bile Acid Diarrhoea: A Feasibility Randomised Controlled Trial
NCT06259396 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Intestinal Microbiome in Obese Kids
NCT00816296 ·Status: WITHDRAWN
-
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
NCT01879735 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency
NCT00006061 ·Status: COMPLETED ·Phase: NA
-
Modulation of Secondary Bile Acids Through the Intestinal Microbiota After Consumption of a High-protein Diet.
NCT05906641 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)
NCT00677521 ·Status: TERMINATED ·Phase: PHASE2
-
Phase I Trial of Silymarin for Chronic Liver Diseases
NCT00389376 ·Status: COMPLETED ·Phase: PHASE1
-
Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver
NCT01423630 ·Status: TERMINATED ·Phase: NA